Home › Funds › Vestal Point Capital, LP › ZYME

Vestal Point Capital, LP position in ZYME

ZYMEWORKS INC · Health Care

Vestal Point Capital, LP reported holding 600,000 shares of ZYME (ZYMEWORKS INC) in its Q3 2026 13F filing — a position valued at US$15.9M, representing 0.41% of its reported portfolio and ranking #32 among its reported holdings. Vestal Point Capital, LP has disclosed ZYME holdings in 8 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)600.00K sh
Reported value held$15.89M
Portfolio Weight0.41%
First reportedQ2 2024
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's ZYME position evolved

Vestal Point Capital, LP first disclosed a stake in ZYME in Q2 2024 at 440,000 shares (US$3.7M). The position peaked in Q3 2025 at 1,765,000 shares, worth US$30.1M. Across 8 filings, Vestal Point Capital, LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 600,000 shares valued at US$15.9M. Notable position changes include a 70% trim in Q4 2024 (shares fell 19% over the following quarter), a 170% increase in Q1 2025 (shares rose 5% over the following quarter), a 130% increase in Q2 2025 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 440.00K $3.74M New
Q3 2024 615.00K $7.72M Add
Q4 2024 185.00K $2.71M Reduce
Q1 2025 500.00K $5.96M Add
Q2 2025 1.15M $14.43M Add
Q3 2025 1.76M $30.15M Add
Q4 2025 865.00K $22.78M Reduce
Q3 2026 600.00K $15.89M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZYME and 13F data

ZYME (ZYMEWORKS INC) is a Health Care company. 27 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$608.5M), Rubric Capital Management LP (US$185.4M), PERCEPTIVE ADVISORS LLC (US$93.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZYME

All ZYME fund holders →

FAQ

How long has Vestal Point Capital, LP held ZYME?

Vestal Point Capital, LP has disclosed ZYME holdings in 8 of the last 10 reported quarters, going back to Q2 2024.

What is Vestal Point Capital, LP's current position in ZYME?

As of Q3 2026, Vestal Point Capital, LP holds 600.00K shares of ZYME (ZYMEWORKS INC), valued at $15.89M, representing 0.41% of its reported portfolio and ranking #32.

Has Vestal Point Capital, LP been buying or selling ZYME?

In the latest 13F filing (Q3 2026), Vestal Point Capital, LP newly opened its position in ZYME. The position peaked in Q3 2025 at 1.76M shares.

Which other funds hold ZYME?

Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.